Related Experiment Videos
[Clinical evaluation of fosfomycin]
1Department of Internal Medicine, Chang Gung Memorial Hospital, Kaoshiung, R.O.C.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|March 1, 1990
Summary
Fosfomycin effectively treated diverse infections in 15 patients, showing high success rates for urinary tract infections and septicemia. This antibiotic demonstrated broad efficacy against various pathogens, including challenging Gram-negative bacteria and resistant Staphylococcus aureus.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Microbiology
Context:
- Fosfomycin is a broad-spectrum antibiotic used to treat bacterial infections.
- The study evaluated fosfomycin's efficacy in a hospital setting.
- Infectious diseases pose a significant global health challenge, necessitating effective antimicrobial agents.
Purpose:
- To assess the clinical effectiveness and microbiological eradication rates of fosfomycin in patients with various infections.
- To determine the safety profile of fosfomycin treatment.
- To identify specific pathogens susceptible to fosfomycin.
Summary:
- Fifteen patients with infectious diseases received intravenous fosfomycin (204g/day for 5-28 days).
- Successful clinical responses were observed in 86% of patients (13/15).
- High efficacy was noted in urinary tract infections (100%), septicemia (80%), and pneumonia (100% of 1 case).
- Pathogen eradication was successful for most isolates, including Escherichia coli, Klebsiella, Pseudomonas aeruginosa, and oxacillin-resistant Staphylococcus aureus.
- Only one patient experienced a skin rash, indicating a favorable safety profile.
Impact:
- Fosfomycin is confirmed as a valuable therapeutic option for treating a range of bacterial infections.
- The study supports fosfomycin's utility against Gram-negative organisms and resistant strains like MRSA and Pseudomonas aeruginosa.
- Findings contribute to understanding fosfomycin's role in managing complex infectious diseases.